Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Patheon 1Q11 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Patheon 1Q11

Commercial manufacturing revenues were up 16% to $148.7 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 1Q11

1Q Revenues: $175.7 million (+12%)

1Q Loss: $500,000 (loss of $11.1 million 1Q10)

Comments: Commercial manufacturing revenues were up 16% to $148.7 million. North American commercial revenues were $5.1 million (+9%). European commercial revenues were $15.5 million (+22%). Pharmaceutical Development Services revenues were $27.0 million (+1%). European commercial revenues benefited from a $30 million reservation payout by a client that chose not to continue a lyophilized cephalosporin project after receiving a complete response letter.


Click here to learn more about Patheon

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters